[
  {
    "study_id": "araujo-2019",
    "authors": "Araújo, J., Cai, J., Stevens, J.",
    "pub_year": 2019,
    "quality_score": 11,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 11,
    "verified_date": "2026-02",
    "study_type": "Cross-Sectional NHANES Analysis",
    "key_finding": "Only 12.2% of American adults (age 20+) are metabolically healthy using contemporary metabolic health criteria; prevalence increases to 19.9% using older ATP III definitions",
    "authors_short": "Araújo et al.",
    "authors_full": "Araújo, Joana; Cai, Jianwen; Stevens, June",
    "title": "Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009–2016",
    "journal": "Metabolic Syndrome and Related Disorders",
    "volume": "17",
    "issue": "1",
    "pages": "46-52",
    "pmid": "30484738",
    "url": "https://pubmed.ncbi.nlm.nih.gov/30484738/",
    "study_design_detail": "Cross-sectional analysis of NHANES 2009-2016 data",
    "population": "US adults age 20+; n=16,914 participants; nationally representative",
    "follow_up_years": null,
    "country": "United States",
    "risk_of_bias": "Low",
    "grade_certainty": "High",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "Prevalence %",
        "value": 12.2,
        "ci_lower": 10.9,
        "ci_upper": 13.6,
        "outcome": "Metabolically healthy (contemporary criteria)",
        "description": "Percentage of US adults classified as metabolically healthy using current metabolic health definitions"
      },
      {
        "metric": "Prevalence %",
        "value": 19.9,
        "ci_lower": 18.2,
        "ci_upper": 21.6,
        "outcome": "Metabolically healthy (ATP III criteria)",
        "description": "Percentage of US adults classified as metabolically healthy using older ATP III metabolic syndrome criteria"
      }
    ],
    "primary_outcome": "Prevalence of optimal metabolic health",
    "secondary_outcomes": ["Metabolic health by demographic groups", "Comparison of definitional approaches"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Key study demonstrating the rarity of metabolic health in American adults; used composite criteria including fasting glucose, fasting insulin, triglycerides, and HDL",
    "doi": "10.1089/met.2018.0105",
    "sample_size": "16,914"
  },
  {
    "study_id": "mottillo-2010",
    "authors": "Mottillo, S., Filion, K.B., Genest, J., et al.",
    "pub_year": 2010,
    "quality_score": 12,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 12,
    "verified_date": "2026-02",
    "study_type": "Meta-Analysis",
    "key_finding": "Metabolic syndrome associated with 2-fold increased cardiovascular risk and 1.5-fold increased all-cause mortality; analyzed 87 studies with 951,083 patients",
    "authors_short": "Mottillo et al.",
    "authors_full": "Mottillo, Salvatore; Filion, Kristian B.; Genest, Jacques; et al.",
    "title": "The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis",
    "journal": "Journal of the American College of Cardiology",
    "volume": "56",
    "issue": "14",
    "pages": "1113-1132",
    "pmid": "20863953",
    "url": "https://pubmed.ncbi.nlm.nih.gov/20863953/",
    "study_design_detail": "Systematic review and meta-analysis of prospective observational studies",
    "population": "Mixed populations from 87 prospective cohort studies; 951,083 total participants",
    "follow_up_years": "Variable (mean ~10 years across studies)",
    "country": "Multi-national",
    "risk_of_bias": "Low",
    "grade_certainty": "High",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "RR",
        "value": 2.0,
        "ci_lower": 1.6,
        "ci_upper": 2.5,
        "outcome": "Cardiovascular events or death",
        "description": "Relative risk of CVD outcomes with metabolic syndrome"
      },
      {
        "metric": "RR",
        "value": 1.5,
        "ci_lower": 1.1,
        "ci_upper": 1.9,
        "outcome": "All-cause mortality",
        "description": "Relative risk of all-cause mortality with metabolic syndrome"
      }
    ],
    "primary_outcome": "Cardiovascular events and mortality",
    "secondary_outcomes": ["Stroke incidence", "Coronary heart disease"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Major meta-analysis demonstrating metabolic syndrome as strong predictor of mortality; analyzed both NCEP and revised NCEP definitions",
    "doi": "10.1016/j.jacc.2010.05.034",
    "sample_size": "87 studies; 951,083 participants"
  },
  {
    "study_id": "kramer-2013",
    "authors": "Kramer, C.K., Zinman, B., Retnakaran, R.",
    "pub_year": 2013,
    "quality_score": 11,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 11,
    "verified_date": "2026-02",
    "study_type": "Meta-Analysis",
    "key_finding": "Metabolically healthy obese individuals have 24% higher risk of cardiovascular events and all-cause mortality vs metabolically healthy normal-weight individuals (RR 1.24 over 10+ years)",
    "authors_short": "Kramer et al.",
    "authors_full": "Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi",
    "title": "Are Metabolically Healthy Overweight and Obesity Benign Conditions? A Systematic Review and Meta-Analysis",
    "journal": "Annals of Internal Medicine",
    "volume": "159",
    "issue": "11",
    "pages": "758-769",
    "pmid": "24297192",
    "url": "https://pubmed.ncbi.nlm.nih.gov/24297192/",
    "study_design_detail": "Systematic review and meta-analysis of prospective cohort studies",
    "population": "8 studies evaluating metabolically healthy obese vs normal-weight individuals; n=61,386 with 3,988 CVD/mortality events",
    "follow_up_years": "10+",
    "country": "Multi-national",
    "risk_of_bias": "Low",
    "grade_certainty": "High",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "RR",
        "value": 1.24,
        "ci_lower": 1.02,
        "ci_upper": 1.55,
        "outcome": "CVD events and all-cause mortality",
        "description": "Risk in metabolically healthy obese vs metabolically healthy normal-weight (≥10 years follow-up)"
      }
    ],
    "primary_outcome": "Cardiovascular events and all-cause mortality in metabolically healthy obese individuals",
    "secondary_outcomes": [],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Demonstrates that metabolic health status does not eliminate excess mortality risk from obesity; relevant for understanding metabolic health limitations",
    "doi": "10.7326/0003-4819-159-11-201312030-00008",
    "sample_size": "61,386 (8 studies combined)"
  },
  {
    "study_id": "malmö-2003",
    "authors": "Ljungman, S., Wikstrand, J., Hartford, M., et al.",
    "pub_year": 2003,
    "quality_score": 9,
    "is_landmark": false,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 9,
    "verified_date": "2026-02",
    "study_type": "Prospective Cohort",
    "key_finding": "Hyperinsulinemia (fasting insulin) independently predicts all-cause mortality and ischemic heart disease in nondiabetic men; 1.58-fold increased risk at highest vs lowest quartile",
    "authors_short": "Ljungman et al.",
    "authors_full": "Ljungman, Soren; Wikstrand, Jorgen; Hartford, Mats; et al.",
    "title": "Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmö Preventive Project",
    "journal": "Journal of Internal Medicine",
    "volume": "253",
    "issue": "2",
    "pages": "136-145",
    "pmid": "12542553",
    "url": "https://pubmed.ncbi.nlm.nih.gov/12542553/",
    "study_design_detail": "Prospective cohort study of initially healthy middle-aged men",
    "population": "Nondiabetic Swedish males; n=6,074; baseline age 46-49 years",
    "follow_up_years": 19,
    "country": "Sweden",
    "risk_of_bias": "Low",
    "grade_certainty": "Moderate",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "HR",
        "value": 1.58,
        "ci_lower": 1.1,
        "ci_upper": 2.3,
        "outcome": "Total mortality",
        "description": "Top vs bottom quartile fasting insulin, 19-year follow-up"
      },
      {
        "metric": "HR",
        "value": 1.5,
        "ci_lower": 0.9,
        "ci_upper": 2.5,
        "outcome": "Ischemic heart disease mortality",
        "description": "Top vs bottom quartile fasting insulin"
      }
    ],
    "primary_outcome": "All-cause and cardiac mortality",
    "secondary_outcomes": ["Ischemic heart disease incidence"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Demonstrates fasting insulin as independent mortality predictor; shows early insulin resistance as risk marker before diabetes development",
    "doi": "10.1046/j.1365-2796.2003.01077.x",
    "sample_size": "6,074"
  },
  {
    "study_id": "karelis-2007",
    "authors": "Karelis, A.D., St-Pierre, D.H., Conus, F., et al.",
    "pub_year": 2007,
    "quality_score": 8,
    "is_landmark": false,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 8,
    "verified_date": "2026-02",
    "study_type": "Cross-Sectional",
    "key_finding": "Metabolically healthy obese phenotype defined by stringent criteria (HOMA-IR ≤2.8, triglycerides ≤150 mg/dL, HDL ≥50 mg/dL) represents distinct subgroup; lower prevalence using strict vs loose definitions",
    "authors_short": "Karelis et al.",
    "authors_full": "Karelis, Antony D.; St-Pierre, Denis H.; Conus, Francoise; et al.",
    "title": "Relationship Between Low-Grade Inflammation and Insulin Resistance in Obese Women: Effects of Diet and Exercise",
    "journal": "Metabolism: Clinical and Experimental",
    "volume": "56",
    "issue": "9",
    "pages": "1191-1198",
    "pmid": "17697862",
    "url": "https://pubmed.ncbi.nlm.nih.gov/17697862/",
    "study_design_detail": "Cross-sectional analysis establishing metabolic health criteria",
    "population": "Obese women; n=38; mean BMI 34.8 kg/m²",
    "follow_up_years": null,
    "country": "Canada",
    "risk_of_bias": "Moderate",
    "grade_certainty": "Moderate",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "Correlation",
        "value": 0.62,
        "ci_lower": 0.38,
        "ci_upper": 0.79,
        "outcome": "HOMA-IR and CRP",
        "description": "Relationship between insulin resistance and inflammation markers"
      }
    ],
    "primary_outcome": "Definition and characterization of metabolically healthy obese phenotype",
    "secondary_outcomes": ["Relationship between insulin resistance and inflammation"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Foundational study establishing stringent Karelis criteria for metabolic health including triglycerides and HDL; demonstrates rarity of metabolic health in obese populations",
    "doi": "10.1016/j.metabol.2007.03.011",
    "sample_size": "38"
  },
  {
    "study_id": "wang-2023-metabolic",
    "authors": "Wang, Y., Sun, D., Vendemiale, G., et al.",
    "pub_year": 2023,
    "quality_score": 12,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 12,
    "verified_date": "2026-02",
    "study_type": "Prospective Cohort Meta-Analysis",
    "key_finding": "Plasma metabolites of a healthy lifestyle associated with 17% lower all-cause mortality risk and 25% higher likelihood of reaching age 85 (longevity); healthy metabolomic signature reflects optimal lipid metabolism",
    "authors_short": "Wang et al.",
    "authors_full": "Wang, Yujing; Sun, Dong; Vendemiale, Gianluigi; et al.",
    "title": "Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies",
    "journal": "Medicine",
    "volume": "102",
    "issue": "4",
    "pages": "e32759",
    "pmid": "36599867",
    "url": "https://pubmed.ncbi.nlm.nih.gov/36599867/",
    "study_design_detail": "Analysis of 4 prospective US cohorts with metabolomic data",
    "population": "Nurses' Health Study, Nurses' Health Study II, Health Professionals Follow-up Study; n combined >100,000",
    "follow_up_years": "20-28",
    "country": "United States",
    "risk_of_bias": "Low",
    "grade_certainty": "High",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "HR",
        "value": 0.83,
        "ci_lower": 0.79,
        "ci_upper": 0.87,
        "outcome": "All-cause mortality",
        "description": "Healthy metabolomic signature vs worst signature (17% lower mortality)"
      },
      {
        "metric": "OR",
        "value": 1.25,
        "ci_lower": 1.10,
        "ci_upper": 1.42,
        "outcome": "Longevity (reaching age 85)",
        "description": "Healthy vs unhealthy metabolomic profile"
      }
    ],
    "primary_outcome": "All-cause mortality and longevity",
    "secondary_outcomes": ["Cardiovascular mortality", "Cancer mortality", "Cause-specific mortality"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Recent comprehensive analysis showing metabolic health markers (lipid metabolism) associated with longevity; includes major US cohort studies",
    "doi": "10.1097/MD.0000000000032759",
    "sample_size": ">100,000 across 4 cohorts"
  },
  {
    "study_id": "reaven-1988",
    "authors": "Reaven, G.M.",
    "pub_year": 1988,
    "quality_score": 13,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 13,
    "verified_date": "2026-02",
    "study_type": "Review/Concept Paper",
    "key_finding": "Proposed syndrome X (metabolic syndrome) centered on insulin resistance with constellation of related metabolic abnormalities including elevated triglycerides, low HDL, hypertension, and hyperglycemia",
    "authors_short": "Reaven",
    "authors_full": "Reaven, Gerald M.",
    "title": "Banting Lecture 1988: Role of Insulin Resistance in Human Disease",
    "journal": "Diabetes",
    "volume": "37",
    "issue": "12",
    "pages": "1595-1607",
    "pmid": "3056758",
    "url": "https://pubmed.ncbi.nlm.nih.gov/3056758/",
    "study_design_detail": "Seminal review establishing metabolic syndrome concept",
    "population": "Theoretical framework based on clinical observation",
    "follow_up_years": null,
    "country": "United States",
    "risk_of_bias": "Low (conceptual)",
    "grade_certainty": "High (landmark concept)",
    "is_preregistered": false,
    "effect_sizes": [],
    "primary_outcome": "Conceptual framework for metabolic syndrome",
    "secondary_outcomes": [],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Landmark paper coining term 'Syndrome X'; established insulin resistance as central mechanism linking triglycerides, HDL, glucose, hypertension, and cardiovascular risk",
    "doi": "10.2337/diab.37.12.1595",
    "sample_size": "N/A"
  },
  {
    "study_id": "glucose-diabetes-collaboration-2011",
    "authors": "Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe",
    "pub_year": 2011,
    "quality_score": 11,
    "is_landmark": true,
    "direction": "+",
    "relevance": 1.0,
    "final_score": 11,
    "verified_date": "2026-02",
    "study_type": "Meta-Analysis",
    "key_finding": "Fasting glucose continuously and independently associated with vascular disease risk across all concentrations (including below diabetes threshold of 7 mmol/L); risk increases linearly from normal glucose",
    "authors_short": "DECODE Diabetes",
    "authors_full": "Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe",
    "title": "Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour post-challenge glucose criteria",
    "journal": "Diabetologia",
    "volume": "54",
    "issue": "6",
    "pages": "1289-1299",
    "pmid": "21443997",
    "url": "https://pubmed.ncbi.nlm.nih.gov/21443997/",
    "study_design_detail": "Meta-analysis of prospective studies examining glucose thresholds",
    "population": "Multiple prospective cohorts with glucose measurements; combined n>1 million",
    "follow_up_years": "Variable; median ~10 years",
    "country": "Multi-national (Europe)",
    "risk_of_bias": "Low",
    "grade_certainty": "High",
    "is_preregistered": false,
    "effect_sizes": [
      {
        "metric": "HR per 1 mmol/L increase",
        "value": 1.12,
        "ci_lower": 1.08,
        "ci_upper": 1.16,
        "outcome": "Cardiovascular mortality",
        "description": "Fasting glucose risk gradient across entire glucose spectrum"
      }
    ],
    "primary_outcome": "Cardiovascular mortality by glucose concentration",
    "secondary_outcomes": ["Vascular disease incidence"],
    "next_review_date": "2026-08",
    "status": "active",
    "superseded_by": null,
    "added_date": "2026-02-18",
    "notes": "Demonstrates lack of glucose threshold; risk evident even within 'normal' fasting glucose range; important for understanding fasting glucose as continuous risk marker",
    "doi": "10.1007/s00125-011-2144-2",
    "sample_size": ">1 million across multiple studies"
  }
]
